XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 175 filers reported holding XENON PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $145,277,903 | -27.3% | 4,252,866 | -18.0% | 0.01% | -23.5% |
| Q2 2023 | $199,765,220 | -41.0% | 5,188,707 | -45.1% | 0.02% | +13.3% |
| Q1 2023 | $338,419,432 | +83.0% | 9,455,698 | +101.6% | 0.02% | -16.7% |
| Q4 2022 | $184,959,387 | +9.7% | 4,690,829 | +0.5% | 0.02% | 0.0% |
| Q3 2022 | $168,578,000 | +21.2% | 4,669,759 | +2.1% | 0.02% | +28.6% |
| Q2 2022 | $139,091,000 | +18.7% | 4,572,368 | +19.3% | 0.01% | +55.6% |
| Q1 2022 | $117,190,000 | -4.1% | 3,833,476 | -2.0% | 0.01% | 0.0% |
| Q4 2021 | $122,149,000 | +161.5% | 3,910,017 | +27.9% | 0.01% | +125.0% |
| Q3 2021 | $46,707,000 | -18.4% | 3,056,756 | -0.5% | 0.00% | 0.0% |
| Q2 2021 | $57,209,000 | +3.5% | 3,072,444 | -0.5% | 0.00% | -20.0% |
| Q1 2021 | $55,262,000 | +36.9% | 3,087,244 | +17.6% | 0.01% | +25.0% |
| Q4 2020 | $40,381,000 | +39.0% | 2,625,552 | +0.0% | 0.00% | +33.3% |
| Q3 2020 | $29,055,000 | +5.4% | 2,624,620 | +19.4% | 0.00% | 0.0% |
| Q2 2020 | $27,576,000 | +53.2% | 2,199,054 | +38.5% | 0.00% | +50.0% |
| Q1 2020 | $18,003,000 | +145.8% | 1,587,536 | +74.3% | 0.00% | +100.0% |
| Q4 2015 | $7,324,000 | -2.7% | 910,920 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $7,524,000 | -42.8% | 910,920 | -20.2% | 0.00% | -50.0% |
| Q2 2015 | $13,157,000 | -37.9% | 1,141,062 | -9.2% | 0.00% | -33.3% |
| Q1 2015 | $21,184,000 | -14.6% | 1,256,239 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $24,811,000 | – | 1,256,239 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
| COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
| TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
| Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
| Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
| GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
| DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
| Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
| Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
| Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |